PubMed:20558148 / 1142-1371
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 7589 | 58-64 | ChemicalEntity | denotes | MK-801 | MESH:D016291 |
| 7590 | 69-72 | ChemicalEntity | denotes | AP7 | MESH:C031231 |
| 7591 | 108-119 | ChemicalEntity | denotes | haloperidol | MESH:D006220 |
| 7592 | 149-158 | DiseaseOrPhenotypicFeature | denotes | catalepsy | MESH:D002375 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 0-229 | Sentence | denotes | The results showed that intracollicular microinjection of MK-801 and AP7 previous to systemic injections of haloperidol significantly attenuated the catalepsy, as indicated by a reduced latency to step down from a horizontal bar. |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 134-144 | GeneOrGeneProduct | denotes | attenuated |
| T34 | 178-185 | GeneOrGeneProduct | denotes | reduced |
| T35 | 197-201 | GeneOrGeneProduct | denotes | step |
| T36 | 225-228 | GeneOrGeneProduct | denotes | bar |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T19 | 134-144 | GeneOrGeneProduct | denotes | attenuated |
| T20 | 178-185 | GeneOrGeneProduct | denotes | reduced |
| T21 | 197-201 | GeneOrGeneProduct | denotes | step |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T4 | 149-158 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T4 | 149-158 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T4 | 149-158 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T23 | 58-64 | ChemicalEntity | denotes | MK-801 | D016291 |
| T24 | 69-72 | ChemicalEntity | denotes | AP7 | ChemicalEntity |
| T25 | 108-119 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T25 | 108-119 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
| T24 | 69-72 | ChemicalEntity | denotes | AP7 | ChemicalEntity | |
| T23 | 58-64 | ChemicalEntity | denotes | MK-801 | D016291 | |
| T82712 | 149-158 | DiseaseOrPhenotypicFeature | denotes | catalepsy | D002375 |